Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Obstet Gynecol. 2022 Apr 1;139(4):616-618. doi: 10.1097/AOG.0000000000004700. Epub 2022 Jan 13.

Authors

Bright P Thilagar¹, Aditya K Ghosh, Jerome Nguyen, Regan N Theiler, Myra J Wick, Ryan T Hurt, Raymund R Razonable, Ravindra Ganesh

Affiliation

¹ Division of General Internal Medicine, the Department of Nursing, the Department of Obstetrics and Gynecology, and the Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota.

Abstract

Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19).

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antibodies, Viral
COVID-19*
Female
Humans
Immunotherapy
Pregnancy
Pregnant Women
SARS-CoV-2

Substances

Antibodies, Monoclonal
Antibodies, Viral